Review highlights the link between insulin resistance and psoriasis severity, suggesting metabolic therapies may improve disease management.
Insulin resistance is increasingly recognised as being closely linked to psoriasis severity and treatment response, rather than simply representing an associated metabolic comorbidity. Emerging evidence for GLP-1 receptor agonists further supports the potential for targeting metabolic dysfunction as part of psoriasis management.
No takes yet. Share an insight, caveat, or question.
Carroll et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: